Ginkgo Bioworks Inc. (DNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ginkgo Bioworks Inc.

    NYSE: DNA · Real-Time Price · USD
    10.91
    -0.24 (-2.15%)
    At close: Sep 08, 2025, 10:13 AM

    Ginkgo Bioworks Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 227.04M 251.46M 477.71M 313.84M
    Cost of Revenue
    		 38.55M 54.01M 204.22M 129.69M
    Gross Profit
    		 188.49M 197.45M 273.49M 184.15M
    Operating Income
    		 -559.76M -864.41M -2.21B -1.83B
    Interest Income
    		 38.61M 57.22M 20.26M 837K
    Pretax Income
    		 -547.51M -892.94M -2.12B -1.84B
    Net Income
    		 -547.03M -892.87M -2.1B -1.83B
    Selling & General & Admin
    		 246.16M 385.02M 1.43B 862.95M
    Research & Development
    		 424.06M 580.62M 1.05B 1.15B
    Other Expenses
    		 78.03M 96.21M n/a n/a
    Operating Expenses
    		 748.25M 1.06B 2.48B 2.01B
    Interest Expense
    		 94K 93K 106K 2.37M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 786.8M 1.12B 2.69B 2.14B
    Income Tax Expense
    		 -479K -71K -15.03M -1.48M
    Shares Outstanding (Basic)
    		 51.89M 48.53M 41.93M 32.95M
    Shares Outstanding (Diluted)
    		 51.89M 48.61M 42M 34.01M
    EPS (Basic)
    		 -10.54 -18.37 -50.15 -53.83
    EPS (Diluted)
    		 -10.54 -18.4 -50.2 -55.53
    EBITDA
    		 -484.39M -821.29M -2.06B -1.81B
    EBIT
    		 -547.41M -892.85M -2.12B -1.84B
    Depreciation & Amortization
    		 63.02M 71.55M 61.63M 29.08M

    Add to Watchlist